SUMMARY: The transcriptional regulation of neuropeptide genes by cAMP is often direeted by a cAMP responsive enhancer (CRE) upstream to the promoter of the genes. The identity of the CRE was determined by transient transfection experiments and has the consensus sequence of 5'-TGACGTCA-3'. A large family of transcription factors have been identified whieh recognize the CRE. Transient transfection assays that employed expression of these faetors driven by vital promoters have determined they can transactivate the neuropeptide gene promoters. Because of the large number of factors that have been identified as being able to recognize the CRE, it has been difficuh to determine which factors mediate in vivo the transactivation of a particular CRE. Using a dominant negative mutant of one of these factors, CREB, it has been determined that both CREB as weil as other factors which do not interact with CREB may mediate the cAMP response of the somatostatin gene.
I. I N T R O D U C T I O N
Several neuropeptides increase in expression in response to increased levels of cellular cAMP (10, 14, 23) . The mechanism behind this induction remained unclear until the cloning of the genes for these neuropeptides. It has since beeome apparent that comparable elements upstream to the promoters in these genes control their response to cAMP (4, 24, 28) . Extensive study of these cAMP-responsive enhancers (CREs) revealed that eren though the sequences are similar there are significant functional differences among them (7) . These variations in the basic motif are likely to confer to the enhancer distinct affinities to the numerous transcription factors that can recognize the CRE, yielding different transeriptional responses to cellular stimuli. The first cloned CRE-binding protein, CREB, was isolated using the CRE from the somatostatin promoter as a probe (12, 15) . CREB falls into the class of basic region leucine zipper (bZIP) transcription factors. These factors have a transactivation domain at the amino-terminus and domains that function in the dimerization of the protein and the reeognition of the DNA enhancer sequence at the carboxy-terminus. Since the original isolation of CREB, a large family of related proteins have been identified that recognize the CRE and are also bZIP proteins (13, 16, 21) . Although all of these factors can dimerize with themselves (homodimers), some are also able to form dimers with each other (heterodimers). Thus, the complex activities of the CRE sequences are matched by the large number of factors, both 93 as homodimers and heterodimers, whieh can reeognize them.
Experiments to determine the transcriptional characteristies of the different CREs, the ability of each factor to transactivate the different CREs, and the mechanism behind the transactivation have been performed both in vitro with cell-free systems and in vivo by transfection into appropriate cell lines. Although cell-free systems have produced significant results, they are not able to mimie the complex signal transduction pathways present in whole cells. Transfection of DNA eonstruets into cell lines has been used to a mueh greater extent in determining the functional charaeteristies of the CREs and CRE-binding protein8.
Analysis of the CRE. The CRE was first identified in the genes for phosphoenolpyruvate carboxykinase (26, 31) and the neuropeptides proenkephalin (4) and somatostatin (24) . The minimal sequence required to maintain the cAMP response was determined by transfection of constructs consisting of the upstream regions placed 5' to a minimal viral promoter controlling the expression of a reporter gene, chloramphenicol acetyhransferase (CAT). Deletional analysis of the upstream regions of these and other genes identified an eight base pair (bp) consensus sequence, 5'-TGACGTCA-3'. Experiments using the endogenous promoter of somatostaün revealed that the CRE also acts as a basal level activator. Unstimulated expression of the somatostaün promoter decreases 10-fold upon deletion of the CRE (2) .
The sequence of the minimal CRE varies among cyclic AMP (cAMP)-responsive genes. A number of genes have the perfect palindromic sequence, 5'-TGACGTCA-3' (24, 27, 30) . However, other genes only have a single copy of the inverted repeat, 5'-CGTCA-3' (4, 26) . Still another has the inverted repeats, but they are separated by a number of nucleotides (28) . The importance of the inverted repeat vs. the single copy CRE is currently unclear. However, point mutations within the palindromic CRE indicate that the two copies of the repeat are not equivalent. In the glycoprotein o~-subunit gene, both mutant sequences 5'-AGACGTCA-3' and 5'-TGACGTCT-3' resuh in reduced basal activities (8) . However, the 5' mutation still elicits a cAMP response whereas the 3' mutation is insensitive to cAMP. The activity of a CRE sequence depends on a number of parameters, including the sequenees adjacent to the CRE, the promoter to which the CRE is attached, and the cell type in which the activity is being assayed. Each of these has been analyzed by transfection experiments. Placement of CREs from a number of different genes on an identical promoter has revealed significant functional differences. The consensus CRE sites and adjacent sequences from the glucagon (-290 to -268), parathyroid hormone (-79 to -62), glycoprotein a-subunit (-128 to -111), and somatostatin (-56 to -33) genes were placed upstream to the glyeoprotein ct-subunit promoter deleted of all endogenous upstream regulatory sequences (7) . Eren though each of these CREs includes the identical eight bp palindrome, they conferred different basal and stimulated activities on the promoter. The glucagon and parathyroid constructs increased basal activity by only 1.5-fold and produced an 8-fold increase in response to cAMP. In contrast, the «-subunit and somatostatin CREs produced basal activities of 7-to 10-fold and stimulated responses of 20-fold. Thus, the activity of a CRE sequence is modulated by sequences immediately adjacent to it.
Both promoter effects and eell-type effects were identified using the CRE from the glycoprotein ct-subunit gene (17) . The o~-subunit CRE has no effect on the basal activity of the minimal OE-subunit promoter when expressed in INRI-G9 cells, a rat islet cell line. However, when placed in front of the minimal somatostatin promoter, basal activity increased by 36-fold. This large difference in basal activity, although directed by the promoter, is dependent on the ceU line used. When these eonstructs are transfected into JEG-3 cells, a human placental cell line, both produce a 2.5-to lO-fold increase in basal activity.
In addition to the interactions between cAMP-responsive elements and their promoters as described above, another level of complexity is added by the interaction between CREs and adjacent enhancer sequences. The CRE located in the glycoprotein a-subunit gene interacts with cis-acting sequences upstream to the enhaneer. This CRE consists of two identical 18 bp repeats in which reside a perfect 8 bp CRE. Immediately upstream to these CREs lies a tissue-specific enhancer which acts to increase both basal and samulated activity by 3-to 5-fold and is completely dependent on the CRE for acüvity (6, 17) .
CRE-binding proteins.
An explanation for the complex pattern of responses among individual CREs is that a variety of different CRE-binding proteins exist, each with its own unique affinity and activity. The initial isolation of some of these proteins has confirmed this hypothesis and has identified a complex super-family of genes that encode CRE-binding proteins. All of these factors isolated to date share the common structural elements of a carboxyterminal basic DNA binding region and a leucine zipper motif (18) . Dimerization of these factors is mediated by the leucine zipper which consists of four to five ieucines separated from each other by seven amino acids. The zippers interact with each other to form a coiled-coil structure (25) . The primary sequence of amino acids in the basic DNA binding domain varies slightly among the different CRE binding proteins, with greater than 50% of the residues present being either lysine or arginine. These factors bind to DNA only as dimers, and each can form a homodimer. Several factors have been shown to form heterodimers. The factors CRE-BP1 and CRE-BP2, for instance, readily form heterodimers with c-jun, a transcription factor in the protein kinase C signal transduction pathway (16, 20) . This may represent a mechanism for crosstalk between the kinase C and kinase A pathways.
In addition to the DNA-binding and leucine zipper domains, all of the CRE binding proteins have amino-terminal regions which are involved in transcriptional activation. Although they are poorly conserved among the class as a whole, they generally have consensus phosphorylation sites for a number of different protein kinases. Transfection experiments have been used extensively to analyze the role of phosphorylation in the mechanism of transactiration by CREB. In some of these experiments, the F9 cell line has been used because it has little endogenous activity on the CRE. Here, the reporter gene containing a CRE sequenee upstream to the promoter is cotransfeeted with a cDNA for CREB driven by a viral promoter and with the cDNA for protein kinase A (PKA) also driven by a vital promoter. The CREB cDNA can be altered by standard molecular biological techniques to produce proteins with point mutations or with entire regions deleted. An alternative technique has been used which involves creating a fusion protein between CREB and the DNA binding domain from the yeast transcription factor, GAL4. In this case, the GAL4 enhancer is placed upstream to the reporter gene. The strength of this technique is that cells with an endogenous cAMP response can be used to analyze CREB mutants because only the CREB fusion proteins can bind to the reporter construct and stimulate transactivation. Experiments using these techniques showed that substitution of the serine in the PKA site with either alanine, glutamic acid, or aspartic acid severely inhibited the ability of CREB to activate transcription (11, 19) . The phosphorylation of CREB by PKA is, however, not sufficient to produce a fully active transcription factor. Additional serine-rieh sequenees near the kinase A site are also necessary for activity (19) . Phosphopeptide mapping of mutant CREB proteins expressed in JEG-3 cells indicated that these "phosphorylation boxes" are modified subsequent to the primary phosphorylation by PKA. Two of these elements, PDE 1 and PDE 2, are II.
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absolutely required for eomplete aetivity. The observation that CREB requires muhiple phosphorylations to be fully active implies that several signaling pathways acting through different kinases could control the activity of CREB.
Because cells express multiple CRE binding proteins, it has been difficult to determine exactly whieh factors are involved in the transactivation of any particular CRE. One method to approach this question would be to eliminate particular factors and assess the remaining cAMP response. We have been able to do this by using a dominant repressor of CREB. This factor, KCREB, is a mutated form of CREB that has a single point mutation in the DNA-binding domain. This mutation not only blocks the ability of the KCREB homodimer to bind DNA, but also inhibits the ability of CREB to bind DNA when in a heterodimer with KCREB (29) . Transfection experiments showed that KCREB will block CREB when both are expressed in the F9 cell line. KCREB was then expressed in the CA-77 cell line which endogenously expresses CREB and produces a strong cAMP-induced expression of the somatostatin promoter. These experiments revealed that the somatostatin CRE may be transactivated both by CREB and by other factors that do not interact with CREB. To these were added 0.5 ml of CaC12 buffer, followed by 0.5 ml BES buffer, and incubated at room temperature for 15 min. The mixtures were then added to each tissue culture plate and the plate incubated overnight at 37 ° C in 3% COz. The media were removed, the cells washed once with PBS, fresh media added, and the cells placed at 37 ° C in 5% CO2. The cells were collected 24 h later. 2. Ca-77 by lipofectin: cells were routinely grown on tissue cuhure plates at 37 ° C in 5% CO z. Cells were plated at 5 X 10s/6-cm dish 18 h before transfection. In 1.0 ml serum-free media, the following DNA was added: 2.5 gg SS-CAT, 2 gg RSV-luciferase, and either RSV-WTCREB or RSV-KCREB as indicated, followed by addition of 30/.tg lipofectin. The total amount of DNA in each transfeetion was 30 gg, the balance being made up with Bluescript. After the cells were rinsed once with serum-free media, 10 ml serum-free media and the lipofectin-DNA mix were added to each tissue culture plate. Serum to normal levels was added after 24 h, followed by addition 6 h later of CPT-eAMP to a final concentration of 0.2 mM. Cells were harvested 36 h after addition of the CPT-cAMP. D. Harvesting of cells: Cells were rinsed twice with 5 mi ice-cold PBS. One milliliter of ice-cold extraction buffer is added to each plate, cells collected with a cell scraper, and placed in an Eppendorf tube. The cells were spun at 4000 rpm, 4 ° C, 5 min in a microcentrifuge. The supernatent was aspirated, the cells resuspended in 0.1 ml extraction buffer, and lysed by three cycles of freeze-thaw by immersion into dry ice and a 37 ° C water bath. Pellet debris was removed by centrifugation, at 15 000 rpm, 4 ° C, 5 min in a microcentrifuge, and the supernatent transferred to a new Eppendorf tube. Supernatents could be stored frozen at -2 0 ° C for at least 2 wk. 
MATERIALS

DISCUSSION
We have used these techniques to examine the ability of a mutated CREB, KCREB, to act as a dominant repressor of CREB in vivo. We had previously determined that in gel shift assays, KCREB would block the ability of CREB to bind to the somatostatin CRE (29) . By transfecting expression vectors for CREB, KCREB, and a reporter construct which would respond to CREB, the ability of KCREB to act as an in vivo dominant repressor of CREB could be tested.
The F9 cell hne used for these experiments has little CRE response by itself and therefore produces little background activity. Because F9 ceUs also have a minimal cAMP response eren when CREB is transfected into the ceUs, an additional expression construct for PKA is required to obtain a stimulated CREB response. In Fig. 1 , F9 ceUs transfected with CREB produce a significant increase in activity when cotransfected with PKA. Increasing the amount of CREB produces a further increase in stimulated acüvity. However, when CREB is cotransfected with an equal amount of the KCREB mutant, the PKA-induced stimulation is blocked. Thus, the KCREB mutant acts as a dominant repressor of CREB function in vivo.
Having identified a tool that can be used to eliminate the activity of CREB in an in vivo situation, we wanted to determine whether it will block an endogenous cAMP-response. The CRE from the somatostatin gene was used for these experiments because CREB was originally cloned using the somatostatin CRE as a probe (12, 15) . Furthermore, CREB can transactivate the somatostatin promoter via the CRE in vivo (1,9,11). However, it has been difficult to get direct evidence that CREB is the endogenous mediator of the cAMP induction of somatostatin. The CA-77 cell line expresses CREB and addition of cAMP analogues to the cuhure medium stimulates transeription of the somatostatin gene. By transfecting KCREB into this ceU line, the in vivo role of CREB in the induction of somatostatin can be assessed.
Both wild type CREB (WTCREB) and KCREB were transfected into CA-77 cells. CAT activity driven by the somatostatin promoter was determined both in unstimulated and eAMP-stimulated eells. The WTCREB produced a modest increase on both basal and stimulated expression (Fig. 2) . The KCREB construct had no effect on basal activity. However, stimulated aetivity was inhibited by 50%. Doubling the amount of transfected KCREB had no further effect on CAT activity.
The mechanism of action of KCREB is to dimerize with the wild-type factor and block its ability to bind the CRE. If other factors can dimerize with KCREB, these may also be inhibited. Thus, ahhough the 50% inhibition of activity indicates that the somatostatin promoter is sensitive to KCREB, there may be factors in addition to CREB responsible for the KCREB-sensitive portion of the induction. The fact that approximately 50% of the induction was insensitive to KCREB suggests that factors in addition to CREB, which do not dimerize with CREB, also participate in the cAMP-induction of the somatostatin promoter.
The expression of specific trans-acting factors and cisacting sequences in cell lines by means of transfection allows many questions to be addressed that are difficuh to approach by in vitro analyses. The ability of factors to transactivate particular enhancer sequences, to respond to particular second messenger pathways and the identification of functional domains within the factors are questions that have all been addressed by transfection into cell lines. Determination of the cis-acting nucleotide sequences required for a partictdar response is also readily approachable by transfection into cell lines. Through the use of appropriate cell lines, transfection experiments dissecting neuropeptide gene expression has produced much information on their mechanism of control and should continue to do so in the future.
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